Crossmark

Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis

Crossref DOI link: https://doi.org/10.1007/s40261-017-0550-z

Published Online: 2017-07-28

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Zeyu

Gong, Yu

Shi, Yuling https://orcid.org/0000-0002-1273-7881
Funding

Funding for this research was provided by:

National Science Foundation of Shanghai (16ZR1426800)

National Science Foundation of China (81673050)
License Information

License valid from 2017-07-28